Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 24

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Therapeutic Efficacy of BIOP 653.1 in a Rabbit Model of Chronic Retinal Neovascularization

Eric Bankaitis; Daniel White; Justin Prater; David Culp

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):224. doi:

ARVO Annual Meeting Abstract June 2021

Single Subcutaneous Dose of Anti-Angiogenesis Drug Safely Suppresses Choroidal Neovascularization Comparable to Intravitreal Aflibercept

Jeffrey Cleland; Rishi Sharma; Santiago Appiani; Minghao Sun; Justin Prater; Siva Kambhampati; David Culp

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):205. doi:

ARVO Annual Meeting Abstract June 2020

Suppression of Murine Choroidal Neovascularization After Systemic Administration of a Targeted Anti-VEGF Therapy

Jeffrey L Cleland; Rishi Sharma; Santiago Appiani; Justin Prater; M. Grazia Spiga; David Culp

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3974. doi:

ARVO Annual Meeting Abstract June 2020

Targeted Sustained Intracellular Delivery to Choroidal Neovascular Lesions After a Single Systemic Administration as Demonstrated by Imaging

Rishi Sharma; Justin Prater; M. Grazia Spiga; David Culp; Kannan Rangaramanujam; Jeffrey L Cleland

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4927. doi:

ARVO Annual Meeting Abstract July 2019

A Pilot Study to Evaluate Surgical Implantation of a Protein-Based Artificial Retina in a Rodent

Nicole Wagner; Jordan Greco; David Culp; Justin Prater; Brian Gilger

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3942. doi:

ARVO Annual Meeting Abstract July 2019

Characterization of the Royal College of Surgeon’s Rat Model Endpoints for Use in Preclinical Ophthalmic Studies

Justin Prater; Vicky Peele; David Culp; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):203. doi:

ARVO Annual Meeting Abstract July 2019

Characterization of a Chronic Panuveitis Model in the Rabbit.

David Culp; Justin Prater; Adam Moser; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):801. doi:

ARVO Annual Meeting Abstract July 2019

Chronic Model of Retinal Neovascularization (RNV) in New Zealand Red Rabbits.

M. Grazia Spiga; Brian C Gilger; David Culp

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2568. doi:

ARVO Annual Meeting Abstract July 2018

ICON-1 Pharmacokinetics after intravitreal and intravenous administration to rabbits

Gabriela Burian; Jacques Gaudreault; Brian C Gilger; David Culp; Thi-Sau Migone

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):231. doi:

ARVO Annual Meeting Abstract July 2018

Episcleral sustained ocular delivery of bromfenac and brinzolamide

Jacklyn H Salmon; Santhi Abbaraju; Shadia Hanna; Lee Hamm; Rasidul Amin; David Culp; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5687. doi:

ARVO Annual Meeting Abstract July 2018

Characterization of a quantitative model of corneal transplantation in the rabbit

David Culp; Grazia Spiga; Justin Prater; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4370. doi:

ARVO Annual Meeting Abstract July 2018

Sunitinib-Loaded Injectable Polymer Depot Formulation for Potential Once per Year Treatment of Neovascular Age-related Macular Degeneration (wet AMD)

Yun Yu; Ward Peterson; Ming Yang; David McKenzie; Delia Cardona; David Culp; Brian C Gilger; Jeffrey Cleland

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):221. doi:

ARVO Annual Meeting Abstract July 2018

Activity of anti-Tissue Factor fusion protein ICON-1 in a swine model of choroidal neovascularization

William Greene; Grazia Spiga; Brian C Gilger; David Culp; Thi-Sau Migone

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):225. doi:

ARVO Annual Meeting Abstract July 2018

Assessment of a pre-clinical model of phacoemulsification and aspiration of cataracts in rabbits

Justin Prater; David Culp; Grazia Spiga; Damian Launer; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2239. doi:

ARVO Annual Meeting Abstract June 2017

Modifications of Sunitinib-Loaded GB-102 Microparticles that Lengthen Drug Release: 9-Months Ocular Tolerability and PK in Rabbit Following IVT Dosing

Ming Yang; Ward Peterson; Yun Yu; Joshua Kays; Delia Cardona; David Culp; Brian C Gilger; David McKenzie; Abraham Anonuevo; Bryan Hoang; Connie Yu; Jeffrey Cleland

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4115. doi:

ARVO Annual Meeting Abstract June 2017

Effect of ST266, an amnion-derived multipotent progenitor cell-derived secretome, in a corneal incision model for post-operative inflammation

Howard Wessel; Elise Gill; Erika Klitsch; Kenneth J Mandell; David Culp; Justin Prater; Brian C Gilger; Larry Brown

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):137. doi:

ARVO Annual Meeting Abstract June 2017

Anti-inflammatory effects of ST266, an amnion-derived multipotent progenitor cell-derived secretome, on corneal wound healing and stromal fibrosis in rabbits

Larry Brown; Howard Wessel; Erika Klitsch; Elise Gill; Justin Prater; David Culp; Brian C Gilger; Kenneth J Mandell

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2644. doi:

ARVO Annual Meeting Abstract June 2017

Anti-allergic effects of ST266, an amnion-derived multipotent progenitor cell-secretome, in ovalbumin-induced allergic conjunctivitis in guinea pigs

Kenneth J Mandell; Howard Wessel; Erika Klitsch; David Culp; Justin Prater; Brian C Gilger; Larry R Brown

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4361. doi:

ARVO Annual Meeting Abstract June 2017

Evaluation of Aflibercept in a Laser-Induced Model of Choroidal Neovascularization in Pigs

David Culp; Samirkumar Rajnikant Patel; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1990. doi:

ARVO Annual Meeting Abstract September 2016

GB-102 for Wet AMD: A Novel Injectable Formulation that Safely Delivers Active Levels of Sunitinib to the Retina and RPE/Choroid for Over Four Months

Ming Yang; Ward M Peterson; Yun Yu; Joshua Kays; Delia Cardona; David Culp; Brian C Gilger; Jeffrey Cleland

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5037. doi:

1 2

Next 20 Results »

Advertisement